Heart Failure With Preserved Ejection Fraction (HFpEF)
62
21
22
16
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.2%
2 terminated out of 62 trials
88.9%
+2.3% vs benchmark
18%
11 trials in Phase 3/4
31%
5 of 16 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 16 completed trials
Clinical Trials (62)
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Non-Interventional Study of Ferretab® Comp. (Ferrous Fumarate + Folic Acid Prolonged-Release Capsules) Effects in Adult Patients With Iron Deficiency Anemia and Cardiovascular Disease
ELEVATE-HFpEF Clinical Study
IRONICA: IRON Repletion In Heart Failure - A Comparison of Oral and IV Approaches
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
Intravenous Iron to Improve Symptoms, Quality of Life and Exercise Capacity in HFpEF With Iron Deficiency
AI-based Echocardiography for Detection of Cardiac Amyloidosis
HFpEF Phenotyping With Echo, Clinical, and Biomarkers
Hearts on Fire: Targeting Inflammation in Heart Failure With Preserved Ejection Fraction
Fecal Microbiota Transplantation for Elderly Patients With HFpEF: A Randomized Controlled Trial
Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF
The Effect of Sacubitril and Valsartan on Heart Function in Chronic Hemodialysis Patients With HFpEF
Clinical Feasibility of Cardiac Neuromodulation Therapy for Heart Failure With Preserved Ejection Fraction
Changes in Intramyocardial Fat Assessed by Cardiac CT Before and After Bariatric Surgery and Their Relationship With Cardiac Diastolic Function
Coronary Artery Stents in Heart Failure With Preserved Ejection Fraction
The Role of Epicardial Adiposity in Heart Failure With Preserved Ejection Fraction
A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)
Intracranial Pressure and a Potential Vicious Circle of Atrial Fibrillation in HFpEF
PREACTIVE: Preconditioning Exercise Intervention to Improve Symptoms and Quality of Life in Comorbid Atrial Fibrillation and HFpEF
Determination of the Prevalence of Unrecognized Heart Failure Among Patients at Risk in Urban Areas Across Germany Using CMR